Published in
Springer Nature [academic journals on nature.com], Prostate Cancer and Prostatic Diseases, 4(24), p. 1167-1180, 2021
DOI: 10.1038/s41391-021-00379-4
Links
Tools
MSH2-deficient prostate tumours have a distinct immune response and clinical outcome compared to MSH2-deficient colorectal or endometrial cancer
Journal article published in 2021 by
Patrick McCoy 
,
Stefano Mangiola ,
Geoff Macintyre,
Ryan Hutchinson,
Ben Tran,
Bernard Pope ,
Peter Georgeson ,
Matthew K. H. Hong ,
Natalie Kurganovs,
Sebastian Lunke,
Michael J. Clarkson,
Marek Cmero ,
Michael Kerger,
Ryan Stuchbery,
Ken Chow
and other authors.
,
Stefano Mangiola ,
Geoff Macintyre,
Ryan Hutchinson,
Ben Tran,
Bernard Pope ,
Peter Georgeson ,
Matthew K. H. Hong ,
Natalie Kurganovs,
Sebastian Lunke,
Michael J. Clarkson,
Marek Cmero ,
Michael Kerger,
Ryan Stuchbery,
Ken Chow
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 